SCHEMBL30719262

SCHEMBL30719262

O=C(OCc1cccc(F)c1)N1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.58
LMNA P02545 3/20 0.54
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 2/20 0.51
HCAR2 Q8TDS4 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 2/20 0.48
HPGD P15428 1/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP12 P39900 1/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
SLC6A3 Q01959 1/20 0.47
CYP2C19 P33261 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1841981 0.84 MEN1 (0.52) GRIN2BLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL4717126 0.83 SMN1; SMN2 (0.49) GRIN2BLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL16825208 0.83 ENPP2 (0.53) LMNASMN1; SMN2ALDH1A1HCAR2MEN1
SCHEMBL5542082 0.83 GRIN2B (0.53) GRIN2BLMNASMN1; SMN2ALDH1A1HCAR2
SCHEMBL28032629 0.82 KMT2A (0.64) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL16825229 0.82 GRIN2B (0.54) GRIN2BSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL794423 0.82 MEN1 (0.69) GRIN2BLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL6557909 0.82 MEN1 (0.69) GRIN2BLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL4710641 0.82 MEN1 (0.69) GRIN2BLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL5537533 0.81 GRIN2B (0.52) GRIN2BLMNAALDH1A1HCAR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117304191-A Fused pyrazine derivatives as A2A/A2B inhibitors 因赛特公司 2023-12-29 CN disclosed